High-risk muscle invasive urothelial carcinoma
Clinical trials for High-risk muscle invasive urothelial carcinoma explained in plain language.
Never miss a new study
Get alerted when new High-risk muscle invasive urothelial carcinoma trials appear
Sign up with your email to follow new studies for High-risk muscle invasive urothelial carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Two-Drug cocktail keep bladder cancer from coming back?
Disease control Recruiting nowThis phase 3 trial is testing whether a combination of two drugs—datopotamab deruxtecan and rilvegostomig—given after surgery can prevent cancer recurrence in people with high-risk muscle invasive bladder cancer. Participants who have had their tumor completely removed will recei…
Matched conditions: HIGH-RISK MUSCLE INVASIVE UROTHELIAL CARCINOMA
Phase 3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Massive german cancer registry aims to uncover best treatments for kidney and bladder cancer
Knowledge-focused Recruiting nowThis study is a large registry that will follow nearly 2,000 people with advanced kidney or bladder cancer in Germany. Researchers will collect information on the treatments patients actually receive, how well they work, and patients' quality of life. The goal is to understand re…
Matched conditions: HIGH-RISK MUSCLE INVASIVE UROTHELIAL CARCINOMA
Sponsor: iOMEDICO AG • Aim: Knowledge-focused
Last updated Jul 16, 2026 00:00 UTC